The GP partnership model is in structural decline. The number of partner GPs in England has fallen every year for over a decade, practice closures are accelerating, and the pipeline of GPs willing to buy into partnership has thinned to the point where many practices simplxy cannot recruit. The BMA's own surveys show that a majority of GP trainees do not intend to become partners.
And yet. Partnership still exists, still functions, and for the right person in the right practice, still offers something no other model does: genuine clinical autonomy, meaningful business upside, and the ability to shape how primary care is delivered in your community.
The question isn't whether partnership is dying. It's whether it's dying fast enough that you shouldn't buy in — or slowly enough that the right opportunity is still worth taking.
What buying in actually costs
The "buy-in" is the capital contribution a new partner makes to acquire their share of the practice's assets — primarily the property (if the practice owns its premises) and sometimes equipment, goodwill, or a notional sum representing the practice's ongoing contractual value.
Property-owning practices: Buy-ins range from £50,000 to £250,000+ depending on the property value and the partner's share. This is typically funded by a bank loan (GP-specific lenders like Wesleyan, BMA-partnered banks, or specialist brokers offer 10–15 year terms). The property share appreciates with the property market and is returned when you leave — in theory. In practice, selling your share depends on finding a replacement partner willing to buy in, which is the central problem.
Non-property-owning practices (rented premises): Buy-ins can be nominal — sometimes as low as £1–£5,000 as a token of commitment. These are increasingly common and remove the capital risk entirely, though they also remove the property investment upside.
Goodwill: Historically practices had significant goodwill value. This has largely evaporated since the 2004 GMS contract changes. Some practices still charge a nominal goodwill figure; most don't.
The hidden cost: Beyond the financial buy-in, partnership carries unlimited personal liability for the practice's debts, contracts, and obligations. This means if the practice faces a large unfunded expense (building repair, staff redundancy, legal action), partners are personally liable. Limited Liability Partnership (LLP) structures mitigate this but are not yet universal.
The financial case for partnership
In a well-run practice, partnership offers the highest potential income of any GP model — and the income is partially within your control, because you directly benefit from the practice's financial performance.
Partners in profitable practices — typically those with strong QOF achievement, enhanced services contracts, PCN DES income, dispensing rights, and efficient cost management — can draw £130,000–180,000 gross. In exceptional cases (large dispensing practices in rural areas), significantly more.
The other financial advantage is the NHS pension. Partners contribute to the NHS Pension Scheme on their drawings, accruing one of the most generous defined-benefit pensions available in the UK. The employer contribution (which the practice pays) adds roughly 20–25% on top of your pensionable income in accrued benefit. Over a 20-year partnership career, the pension value alone can exceed £1 million in present terms.
Property ownership adds a further dimension: if the practice owns its building, your capital share grows with property values and you receive notional rent (effectively rent paid by the NHS to your own partnership for occupying the building). This is tax-efficient capital growth that most investment vehicles can't match.
The financial case against partnership
The BMA's recommended minimum for a salaried GP doing equivalent sessions is now high enough that the income premium for partnership has narrowed significantly — particularly when you adjust for the unpaid management time, financial risk, and stress that partners absorb.
Expenses are rising faster than income. Staff costs, locum cover, premises maintenance, and regulatory compliance (CQC, information governance, training requirements) all grow annually. NHS contract uplifts have consistently lagged behind cost inflation, squeezing partner margins year on year.
List size volatility. Practice income is largely driven by weighted patient numbers. In areas with population decline or where new practices/providers enter the market, list sizes can fall — taking income with them while fixed costs remain.
The recruitment trap. When a partner leaves and can't be replaced, the remaining partners absorb both the clinical workload and the financial overhead. This creates a vicious cycle: more work per partner → more burnout → more departures → fewer partners to share the burden. Many practice failures follow this pattern.
The exit problem. Getting out of partnership can be slow, contractually complex, and financially disappointing. Notice periods are typically 6–12 months. If the remaining partners can't find a replacement, your capital may be tied up for years. Restrictive covenants may prevent you from working nearby. The partnership agreement you signed on the way in becomes the document that governs your exit — and many GPs sign without fully understanding the implications.
What to look for if you're considering buying in
Not all partnerships are equal. The factors that differentiate a good opportunity from a trap:
The partnership agreement itself. Read it with a specialist solicitor before signing. Key clauses: notice period, restrictive covenant radius and duration, capital repayment terms and timeline, maternity/paternity provisions, expulsion procedure, and what happens to your share if the practice closes. If the agreement is more than 10 years old and hasn't been updated, that's a red flag.
The practice accounts. Request 3 years of audited accounts. Look at: income trend (stable, growing, or declining?), expense ratio, locum spend (a proxy for workforce stability), and per-partner drawings trend. If drawings have been flat or declining while NHS contract uplifts have been positive, that means expenses are eating the growth.
The partnership dynamic. Talk to the existing partners individually, not just in the formal interview. How do they make decisions? How do they handle disagreements? What's the age profile — are you joining a young, stable team or replacing the first of three partners approaching retirement?
The premises situation. Property ownership is an asset but also a liability. What's the condition of the building? Are there upcoming maintenance obligations (roof, heating, accessibility compliance)? Is the notional rent valuation current? If the building needs £200,000 of work, that comes from partners' pockets.
The PCN and local system. How engaged is the practice with its PCN? Is the PCN functional or dysfunctional? What's the ICB's stance on primary care investment in the area? These factors increasingly determine whether a practice thrives or merely survives.
The alternative models emerging
The traditional equity partnership isn't the only option:
Salaried-plus models: Some practices offer salaried GPs enhanced terms — higher session rates, profit share, management allowances — that approximate partnership income without the capital commitment or liability. These are increasingly common as practices struggle to recruit full partners.
LLP structures: Limited Liability Partnerships cap personal financial exposure. More practices are converting to LLP, which makes partnership more palatable for risk-averse candidates.
GP federations and super-partnerships: Larger-scale organisations offer economies of scale, shared management burden, and (sometimes) better negotiating power with ICBs. The trade-off is reduced autonomy and the risk of bureaucratic overhead replicating the problems of secondary care management.
APMS contracts: Alternative Provider Medical Services contracts allow non-traditional providers (including companies, social enterprises, and groups of GPs) to deliver primary care. These offer different risk/reward profiles and may suit GPs who want business involvement without traditional partnership.
The honest answer
Is GP partnership worth it in 2026? It depends entirely on the specific practice, the specific agreement, your financial situation, your career stage, and your tolerance for risk and management responsibility.
The model is under pressure but it hasn't collapsed — and in the right circumstances, it still offers financial returns, professional autonomy, and career satisfaction that no other GP working model matches. The GPs who regret buying in are typically those who didn't scrutinise the accounts, didn't read the partnership agreement properly, or joined a practice already in decline hoping they could turn it around single-handedly.
The GPs who thrive in partnership are typically those who chose carefully, negotiated firmly, and went in with open eyes about both the upside and the obligations.
If you're considering it: get independent financial advice, get a specialist solicitor, read the accounts like you'd read an investigation result — looking for what's abnormal, not just what's reassuring — and talk to GPs who've left the practice, not just those who are selling you the opportunity.
iatroX is built by a practising NHS GP. Tools include AI clinical search, NICE-aligned guidelines, and CPD tracking.